Immunome (IMNM) Change in Account Payables (2019 - 2026)
Immunome (IMNM) posted Change in Account Payables of $1.4 million for Q1 2026, up 162.41% on a QoQ basis from -$2.3 million in Q4 2025, and up 137.3% year-over-year from $598828.7 in Q1 2025.
Immunome (IMNM) Change in Account Payables (2019 - 2026) Analysis & Trends
Immunome's Change in Account Payables history runs 8 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- Quarterly Change in Account Payables rose 137.3% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.9 million (down 218.46% YoY) and the FY2025 annual result came in at -$9.2 million, down 196.2% from the prior year.
- Change in Account Payables was $1.4 million for Q1 2026 at Immunome, up from -$2.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $9.3 million in Q4 2024 and bottomed at -$4.9 million in Q2 2025.
- A 5-year average of $29294.1 and a median of -$32000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables soared 1465.24% — and 2025, when it sank 15362.5%.
- Immunome's Change in Account Payables stood at -$739000.0 in 2022, then rose by 8.12% to -$679000.0 in 2023, then surged by 1465.24% to $9.3 million in 2024, then sank by 124.56% to -$2.3 million in 2025, then surged by 162.41% to $1.4 million in 2026.
- Business Quant data shows IMNM's Change in Account Payables at $1.4 million in Q1 2026, -$2.3 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.86 Mn |
| 10 | Immunome | 2.51 Bn | 1.93 Bn | - | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | -4.95 Mn |
| Jun 30, 2025 | -4.95 Mn |
| Mar 31, 2025 | -3.81 Mn |
| Mar 31, 2025 | -3.81 Mn |
| Dec 31, 2024 | 9.27 Mn |
| Dec 31, 2024 | 9.27 Mn |
| Sep 30, 2024 | -2.11 Mn |
| Sep 30, 2024 | -2.11 Mn |
| Jun 30, 2024 | -32,000.00 |
| Jun 30, 2024 | -32,000.00 |
| Mar 31, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | -679,000.00 |
| Dec 31, 2023 | -679,000.00 |